Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Patients With EGFR T790M Positive Advanced Non Small Cell Lung Cancer Who Progressed on Prior Therapy With EGFR TKIs

NCT02330367 is registered in ClinicalTrials.gov with Hangzhou ACEA Pharmaceutical Research Co., Ltd. as lead sponsor.

NCT NCT02330367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02330367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Patients With EGFR T790M Positive Advanced Non Small Cell Lung Cancer Who Progressed on Prior Therapy With EGFR TKIs
Lead sponsor
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2015
Completion date
March 31, 2023
Enrollment
368 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic non-small cell lung cancer